期刊文献+

加兰他敏市场前景浅析 被引量:14

An Analysis of the Market Prospect of Galantamine
下载PDF
导出
摘要 目的探讨加兰他敏原料药、制剂市场的发展前景。方法分析加兰他敏野生资源分布与人工栽培,及其外消旋体与对映体的化学合成进展状况。结果与结论加兰他敏原料药和制剂市场将保持供需两旺,其左旋对映体原料的市场垄断仍将维持。生产加兰他敏制剂的前景看好,但由于竞争者加入,其竞争压力开始增大。 OBJECTIVE: To analyze the market prospect of the raw material and the preparations of galantaminc. METHODS: Comprehensivelly analyzing the status of the wildlife and the planting herb resource of galantamine, and the progress of synthesizing racemized galantamine and it's enantiomer. RESULTS & CONCLUSION: The supply and demand of galantamine raw material and its preparations keep blooming. The raw material of enantiomer ( - ) galanthamine keeps monopolized. Galantamine preparation has a good market prospect, but its pressure of eompetition will increase for more competitors are thrusting in.
出处 《中国药房》 CAS CSCD 北大核心 2006年第22期1690-1692,共3页 China Pharmacy
关键词 加兰他敏 胆碱酯酶抑制剂 老年痴呆症 石蒜 诺维定 Glantamine Cholinesterase inhibitor Alzheimer's disease Lycoris radiata Narwedine
  • 相关文献

参考文献15

  • 1Alan LH.The pharmacology of galanthamine and its analogues[J].Pharmac Ther,1995,168(1):113.
  • 2加拿大-中国商会.石蒜提取物:加兰他敏高纯度生物碱[EB/OL].http://www.ccba.bc.ca/discussl/-discl/0000042f.htm.
  • 3忠县外宣网.忠县石蒜生产基地建设项目[EB/OL].http:// www.zx.xinhua023.com/ Show Article.asp?ArticleID = 4690,2005,7,19.
  • 4第三届福建省网上投资贸易洽谈会网.福建利科生物技术有限公司[EB/OL].http://invite.fjfair.com/intro.asp?area-id=&type=sup&e-id=21,2006,6,23.
  • 5江苏省中科院植物研究所.石蒜综合利用及新产品开发[EB/OL].http://www.njbas.ac.cn/chengguo/sszh.htm,2006,6,23.
  • 6刘涛,钱超,陈新志.外消旋加兰他敏全合成研究[J].浙江大学学报(工学版),2006,40(3):520-523. 被引量:12
  • 7阎家麒.一种加兰他敏全合成的方法[P].中国:CN-1554658,2004,12,15.
  • 8Shieh,Wen C.Method of manufacture of(一)-galanthamine in high yield and purity substantially free of epigalanthamine[P].USA:5428159,1995,1,27.
  • 9Potter,Gerard A.Process for preparing single enantiomer narwedine[P].USA:6392038,2002,5,21.
  • 10Bolugoddu,Vijaya B.Preparation of(一)-galantamine hydrobromide[P].USA:20060009640,2006,1,12.

二级参考文献10

  • 1SCOTT L J,GOA K L.Galanthamine:a review of its use in Alzheimer's disease [J].Drugs,2000,60 (5) :1095.
  • 2BARTON D,KIRBY G W,The synthesis of galanthamine [J].Journal Chemical Society,1962:806 -817.
  • 3DAVID A C,NEIL F.Peter David Tiffin.Galanthamine derivatives and process for their preparation[P].US,6 093 815,2000.
  • 4BERNHARD K,LASZLO C,JOHANNES F,et al.Development of a pilot Scale process for the anti-Alzheimer drug (-)-galanthamine using large-scale phenolic oxidative coupling and crystallization-induced chiral conversion [J].Organic Process Research & Development,1999,3:425 - 431.
  • 5BARRY M,TROST F,DEAN T.Enantioselective total synthesis of (-)-galanthamine [J].Journal American Chemical Society,2000,122:11262 - 11263.
  • 6БУЛАВКАВН,ТОЛКАЧЕВОН,ЩАВЛИНСКИЙАН.Оселективномдеметилировании 2-бром-4,5-диметоксибензальдегидаю [J].Химико-ФармакогностичискийЖурнал,1990,24(5):59 - 60.
  • 7JERZY S,ANITA H L,CARROLL F I.An improved synthesis of galanthamine [J].Journal Hete-rocylic Chemistry,1988,25:1809 - 1811.
  • 8БУЛАВКАВН,ТОЛКАЧЕВОН,ЩАВЛИНСКИАН.Региоселективноебромирование 3-гидрокси-4-метоксебензальдегида [J].Химико-ФармакогностичискийЖурнал.1991,25(2) :46 - 68.
  • 9BULAVKA V N,TOLKACHEV O N,ShCHAVLINSKⅡ A N.Selective demethylation of 2-bromo-4,5- djmethoxybenzaldehyde [J].Khimiko-Farmat-sevticheskii Zhurnal,1990,24(5):59 - 60.
  • 10BULAVKA V N,TOLKACHEV O N,SHCHAVLINSKⅡ A N.Regioselective bromination of 3-hydroxy-4-methoxybenzaldehyde [J].Khimiko-Farmatsev-ticheskii Zhurnal,1991,25(2) :46 - 8.

共引文献11

同被引文献112

引证文献14

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部